Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 12/2015

01-12-2015 | Erratum

Erratum to: Abstracts of the 51st Annual Meeting of the EASD, Stockholm 2015. ‘Dapagliflozin reduces albuminuria on top of renin-angiotensin system blockade in hypertensive patients with diabetes’

Authors: H. J. Lambers Heerspink, E. Johnsson, I. Gause-Nilsson, C. Sjöström

Published in: Diabetologia | Issue 12/2015

Login to get access

Excerpt

Erratum to: Diabetologia …
Metadata
Title
Erratum to: Abstracts of the 51st Annual Meeting of the EASD, Stockholm 2015. ‘Dapagliflozin reduces albuminuria on top of renin-angiotensin system blockade in hypertensive patients with diabetes’
Authors
H. J. Lambers Heerspink
E. Johnsson
I. Gause-Nilsson
C. Sjöström
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 12/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3765-7

Other articles of this Issue 12/2015

Diabetologia 12/2015 Go to the issue

Article

Heterozygous inactivation of plasma membrane Ca2+-ATPase in mice increases glucose-induced insulin release and beta cell proliferation, mass and viability

Article

Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes

Article

A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes

Article

Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study

Article

Obesity resistance and increased energy expenditure by white adipose tissue browning in Oga +/- mice

Article

Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits